Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The current ratio is N/A as of Tuesday, October 6, 2026.
CURRENT RATIO
N/A
Market Cap
$153.58M
Current Ratio
0.45
TTM Avg
0.24
3Y Avg
0.20
5Y Avg
0.38
Market Cap
$151.01M
Current Ratio
5.55
TTM Avg
4.34
3Y Avg
4.83
5Y Avg
5.46
Market Cap
$149.36M
Current Ratio
9.71
TTM Avg
4.67
3Y Avg
6.04
5Y Avg
19.74
Market Cap
$148.73M
Current Ratio
0.82
TTM Avg
5.49
3Y Avg
4.19
5Y Avg
4.20
Market Cap
$148.64M
Current Ratio
7.51
TTM Avg
6.60
3Y Avg
4.97
5Y Avg
4.99
Market Cap
$148.27M
Current Ratio
15.62
TTM Avg
10.23
3Y Avg
11.93
5Y Avg
11.24
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Veraxa Biotech Holding AG (VRXA) | $152.72M | N/A | N/A | N/A | N/A |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $153.58M | 0.45 | 0.24 | 0.20 | 0.38 |
| Neuronetics, Inc. (STIM)vs › | $153.79M | 1.88 | 1.94 | 2.90 | 3.95 |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.01M | 5.55 | 4.34 | 4.83 | 5.46 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $149.36M | 9.71 | 4.67 | 6.04 | 19.74 |
| Inogen, Inc. (INGN)vs › | $156.22M | 2.74 | 2.77 | 3.26 | 3.97 |
| Korsana Biosciences, Inc. (KRSA)vs › | $148.73M | 0.82 | 5.49 | 4.19 | 4.20 |
| Voyager Therapeutics, Inc. (VYGR)vs › | $148.64M | 7.51 | 6.60 | 4.97 | 4.99 |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.27M | 15.62 | 10.23 | 11.93 | 11.24 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.62M | 2.47 | 5.27 | 13.16 | 16.37 |
Current Ratio
N/A
Quick Ratio
N/A
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
